Novo Nordisk Healthcare AG et al v. Laboratoire Francais du Fractionnement et des Biotechnologies S.A. et al
| Novo Nordisk Inc. and Novo Nordisk Healthcare AG |
| Laboratoire Francais du Fractionnement et des Biotechnologies S.A. and Hema Biologics, LLC |
| 1:2020cv00580 |
| April 28, 2020 |
| U.S. District Court for the District of Delaware |
| Leonard P Stark |
| Patent |
| 35 U.S.C. § 271 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on June 10, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
SO ORDERED, re #12 MOTION for Pro Hac Vice Appearance of Attorney Michael Houston, George E. Quillin, Jason Mock, Tiffany K. Sung and Jayita Guhaniyogi filed by Laboratoire Francais du Fractionnement et des Biotechnologies S.A., #13 MOTION for Pro Hac Vice Appearance of Attorney Jeffrey J. Oelke, Catherine H. McCord, and Kathryn E. Easterling filed by Novo Nordisk Healthcare AG, Novo Nordisk Inc. Signed by Judge Leonard P. Stark on 6/10/20. (ntl)
|
| Filing 13 MOTION for Pro Hac Vice Appearance of Attorney Jeffrey J. Oelke, Catherine H. McCord, and Kathryn E. Easterling - filed by Novo Nordisk Healthcare AG, Novo Nordisk Inc.. (Egan, Brian) |
| Filing 12 MOTION for Pro Hac Vice Appearance of Attorney Michael Houston, George E. Quillin, Jason Mock, Tiffany K. Sung and Jayita Guhaniyogi - filed by Laboratoire Francais du Fractionnement et des Biotechnologies S.A.. (Kraftschik, Stephen) |
| Pro Hac Vice Attorney Jane M. Love for Hema Biologics, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Filing 11 NOTICE of Appearance by Stephen J. Kraftschik on behalf of Laboratoire Francais du Fractionnement et des Biotechnologies S.A. (Kraftschik, Stephen) |
|
SO ORDERED, re #10 STIPULATION TO EXTEND TIME for Defendants HEMA Biologics, LLC and Laboratoire Francais du Fractionnement et des Biotechnologies S.A. to answer or otherwise respond to the Complaint to July 20, 2020 filed by Novo Nordisk Healthcare AG, Novo Nordisk Inc. Signed by Judge Leonard P. Stark on 5/21/20. (ntl)
|
| Filing 10 STIPULATION TO EXTEND TIME for Defendants HEMA Biologics, LLC and Laboratoire Francais du Fractionnement et des Biotechnologies S.A. to answer or otherwise respond to the Complaint to July 20, 2020 - filed by Novo Nordisk Healthcare AG, Novo Nordisk Inc.. (Egan, Brian) |
|
SO ORDERED, re #9 MOTION for Pro Hac Vice Appearance of Attorney Jane M. Love and Ronald A. Lee filed by Hema Biologics, LLC. Signed by Judge Leonard P. Stark on 5/15/20. (ntl)
|
| Pro Hac Vice Attorney Ronald A. Lee for Hema Biologics, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Filing 9 MOTION for Pro Hac Vice Appearance of Attorney Jane M. Love and Ronald A. Lee - filed by Hema Biologics, LLC. (Attachments: #1 Certifications for Jane M. Love and Ronald A. Lee)(Silver, Daniel) |
| Filing 8 NOTICE of Appearance by Alexandra M. Joyce on behalf of Hema Biologics, LLC (Joyce, Alexandra) |
| Filing 7 NOTICE of Appearance by Daniel M. Silver on behalf of Hema Biologics, LLC (Silver, Daniel) |
| Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Filing 6 SUMMONS Returned Executed by Novo Nordisk Inc., Novo Nordisk Healthcare AG. Hema Biologics, LLC served on 4/29/2020, answer due 5/20/2020. (Egan, Brian) |
| Filing 5 Summonses Issued (please complete the top portion of the form and print out for use/service). (mal) |
| Filing 4 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novo Nordisk US Holdings Inc. for Novo Nordisk Inc.; Corporate Parent Novo Nordisk A/S for Novo Nordisk Healthcare AG. Novo Nordisk US Holdings Inc. is a privately held corporation wholly owned by Novo Nordisk A/S filed by Novo Nordisk Healthcare AG, Novo Nordisk Inc.. (mal) |
| Filing 3 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,102,762 B2. (mal) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT - filed with Jury Demand against Hema Biologics, LLC, Laboratoire Francais du Fractionnement et des Biotechnologies S.A. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2909209.) - filed by Novo Nordisk Inc., Novo Nordisk Healthcare AG. (Attachments: #1 Exhibit A-F, #2 Civil Cover Sheet)(mal) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
